Purchase Order 75F40119P10219
- Not listed
- This firm fixed-price purchase order, awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Olink Proteomics AB, a foreign-owned for-profit manufacturer based in Sweden, is for $48,240.00 to provide inflammatory and immune response protein analysis services. The contract does not have a set-aside designation. Olink Proteomics AB has provided similar proteomics analysis services to various federal agencies, including the National Institutes of Health (NIH), Food and Drug...
- This is a $79,345.00 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The contract is for quantitative proteomics measurement of human COVID-19 plasma samples, which supports the FDA's research efforts related to the COVID-19 pandemic. Olink Proteomics specializes in protein biomarker discovery and has provided a range of proteomics instruments, reagents, and analysis services to various...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Olink Proteomics AB, a foreign-owned for-profit organization based in Sweden, to provide 200 samples of Olink Explore 3072 protein analysis services for $140,000. The services will be performed in Watertown, Massachusetts. This award was made under a simplified acquisition without any set-aside, and the original solicitation...
- This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Olink Proteomics AB, a foreign-owned for-profit manufacturer based in Sweden. The $85,000.00 contract is for the delivery of 10 inflammation reagent kits and associated array chips to support NIAID's biomedical research efforts, particularly in the areas of cancer, cardiovascular disease, infectious...
- The Food and Drug Administration (FDA) awarded a $94,500 firm fixed-price purchase order to Olink Proteomics AB, a foreign-owned manufacturer of protein biomarker analysis technologies and services. The contract is for quantitative proteomics measurement of cardiotoxicity biomarkers in 150 human plasma samples using Olink's proprietary Explore 1536 multiplex analysis platform. This purchase order was awarded without a set-aside and is not associated with a larger contract vehicle. Olink...
- This is a firm fixed price purchase order for $34,902.00 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, to Olink Proteomics AB, a foreign-owned for-profit entity based in Sweden. The contract is for the delivery of Olink Proteomics' proprietary Inflammation reagent kits and Dynamic Array chips, which support multiplex protein biomarker analysis. This purchase order was awarded under simplified acquisition procedures...
- This firm fixed-price purchase order was awarded by the Veterans Integrated Service Network 1 (VISN 1), a division of the U.S. Department of Veterans Affairs (VA), to Olink Proteomics AB, a foreign-owned for-profit company based in Sweden. The $5,466 contract is for inflammatory protein profiling services to support biomedical research, with a period of performance ending on May 16, 2022. Olink Proteomics specializes in multiplex protein biomarker analysis technologies and has provided similar...
- This is a firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), to Olink Proteomics AB, a foreign-owned for-profit company based in Sweden. The $69,388 contract is for Olink to provide laboratory services, specifically protein biomarker analysis using their proprietary multiplex platforms, to support NICHD's biomedical research across disease areas such as cancer, cardiovascular disease,...
- The Department of Health and Human Services, National Institutes of Health, National Human Genome Research Institute awarded a firm fixed price purchase order contract to Olink Proteomics AB, a foreign-owned for-profit organization, to evaluate multiple proteins in plasma samples. The $247,996.10 contract has a performance period ending on May 13, 2023. No set-aside designation was used for this award. Olink Proteomics AB specializes in proprietary multiplex protein biomarker analysis...
- This is a $147,501.31 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The contract, which has no set-aside designation, is for the acquisition of Olink's O-Link System and reagents. Olink Proteomics specializes in protein biomarker discovery solutions and has provided a variety of proteomics instruments, assay kits, and analysis services to support government research efforts,...
This firm fixed price purchase order contract was awarded by the Food and Drug Administration (FDA) to Olink Proteomics AB, a foreign-owned for-profit manufacturer based in Sweden. The $75,718 contract is for the provision of proteomics analysis services, including the analysis of plasma samples to support biomedical research across disease areas such as cancer, cardiovascular disease, infectious disease, and COVID-19. Olink has previously provided similar services to federal agencies like the National Institutes of Health (NIH) and the Department of Veterans Affairs (VA). The original solicitation was likely a sole-source award to Olink to ensure data comparability across the agency's research efforts evaluating circulating biomarkers. This contract is not associated with a larger indefinite delivery vehicle, and there was no set-aside designation.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Proteomics Analysis | FDA-RFQ-1212692 | Department of Health and Human Services Food and Drug Administration | Award Notice 1/1 | 5/9/19, 5:35 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | $0 | 6/25/25 | |
| Not listed | Not listed | $75.7k | 6/5/19 |